Clinical Trial Update: Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating copanlisib in combination with T-DM1 for pretreated unresectable locally advanced or metastatic HER2-positive breast cancer has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Unresectable Breast Cancer

Drugs mentioned

• Aliqopa (copanlisib)
• Kadcyla (ado-trastuzumab emtansine)

Snippet

Sponsor: Cancer Trials Ireland | Conditions: HER2-positive Breast Cancer, Metastatic Breast Cancer | Phase 1 | Status: TERMINATED